Concepedia

Mark R. Kelley

MR

Statistics

Publications

11

Citations

264

H-Index

11

Active since

2018

Affiliations

Indiana University School of Medicine(Current)

Indiana University – Purdue University Indianapolis

Indiana University Health

ApeX Therapeutics (United States)

Mark R. Kelley is an author at Indiana University School of Medicine specializing in molecular biology, oncology, and life sciences.

Publications per year

2018–2024

11

Publications

11

Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis

Lauren Sahakian, Rhiannon T. Filippone, Rhian Stavely et al. · Inflammatory Bowel Diseases · 2020 · 49 citations · Full text

Life Sciences, Pathobiology, Pharmacology +17

Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization

Sheik Pran Babu Sardar Pasha, Kamakshi Sishtla, Rania S. Sulaiman et al. · PubMed Central · 2018 · 48 citations · Full text

Medicine, Medicinal Chemistry, Ophthalmology +10

APE1/Ref-1 – One Target with Multiple Indications: Emerging Aspects and New Directions

Mahmut Mijit, Rachel A. Caston, Silpa Gampala et al. · Journal of Cellular Signaling · 2021 · 39 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +15

New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types

Silpa Gampala, Hye‐ran Moon, Randall Wireman et al. · Pharmacological Research · 2024 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

Activation of the integrated stress response (ISR) pathways in response to Ref-1 inhibition in human pancreatic cancer and its tumor microenvironment

Mahmut Mijit, Megan Boner, Ricardo A. Cordova et al. · Frontiers in Medicine · 2023 · 20 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 11